Press Releases

Aurion Biotech to Present Clinical Trial Results at the 2023 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting

Go to article

March Milestone

Go to article

Aurion Biotech Receives Approval from Japan’s PMDA for New Drug Application

Go to article

Jonathan Sparks, JD, PhD Joins Aurion Biotech as Chief Legal Officer

Go to article

Aurion Biotech Expands Its Leadership Team

Go to article

Aurion Biotech Wins Prestigious Prix Galien Startup Award

Go to article

Living Our Values at Aurion Biotech

Go to article

A Culture of Curiosity and Collaboration

Go to article

Summer Solstice or Mid-year Madness? 

Go to article

Aurion Biotech Appoints Dr. Michael Goldstein as President and Chief Medical Officer

Go to article

Aurion Biotech Wins ASCRS Eyecelerator Award

Go to article

AURION BIOTECH RAISES $120 MILLION FROM DEERFIELD, PETRICHOR, FLYING L PARTNERS, FALCON VISION/KKR AND VISIONARY VENTURES

Go to article

Greg Kunst Appointed CEO of Aurion Biotech

Go to article

Why I Joined Aurion Biotech

Go to article

Aurion Biotech Wins “Best in Show” at AAO Eyecelerator Conference

Go to article

Aurion Biotech Announces Medical Advisory Board

Go to article

Aurion Biotech Announces Strategic Investments in Manufacturing

Go to article

Aurion Biotech Announces IOTA Cell Therapy Trial

Go to article

Planes, Trains and…Hurricanes?

Go to article

Aurion Biotech Appoints Professor Shigeru Kinoshita, MD, PhD, to Its Medical Advisory Board

Go to article

Aurion Biotech Names Edward Holland, MD, Chair of Medical Advisory Board

Go to article

What Drive Success? A Conversation with Dr. Edward Holland

Go to article

Arnaud Lacoste Joins Aurion Biotech as Chief Scientific Officer

Go to article

When We Reach the End of What We Should Know

Go to article

In the News

Genetic Engineering & Biotechnology News: Aurion Biotech Industrializing Ophthalmologic Cell-Based Therapy

Go to article

BioSpace: How You React Now Determines Your Next Success

Go to article

Ophthalmology Times: Exploratory Trials in Cell Therapy

Go to article

The New England Journal of Medicine: Injection of Cultured Cells With a ROCK Inhibitor for Bullous Keratopathy

Go to article

AAO Ophthalmology Journal: Five-Year Follow-up...Cultured Corneal Endothelial Cells

Go to article

Corneal Physician: Injectable Corneal Endothelial Cells

Go to article

JAMA Ophthalmology: Global Survey of Corneal Transplantation & Eye Banking

Go to article